Who should be prioritised for COVID-19 vaccination?

被引:52
|
作者
Russell, Fiona M. [1 ,2 ]
Greenwood, Brian [3 ]
机构
[1] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Asia Pacific Hlth Res, Melbourne, Vic, Australia
[3] London Sch Hyg & Trop Med, Dept Dis Control, London, England
基金
英国医学研究理事会;
关键词
COVID-19; vaccines; high-risk; epidemiology; transmission; vaccine development; clinical trials; WOMEN;
D O I
10.1080/21645515.2020.1827882
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
引用
收藏
页码:1317 / 1321
页数:5
相关论文
共 50 条
  • [42] Cutaneous manifestations of COVID-19 and COVID-19 vaccination
    Nakashima, Chisa
    Kato, Maiko
    Otsuka, Atsushi
    JOURNAL OF DERMATOLOGY, 2023, 50 (03): : 280 - 289
  • [43] COVID-19 in children and the importance of COVID-19 vaccination
    Feng-Xia Xue
    Kun-Ling Shen
    World Journal of Pediatrics, 2021, 17 : 462 - 466
  • [44] Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
    De Michele, Manuela
    Kahan, Joshua
    Berto, Irene
    Schiavo, Oscar G.
    Iacobucci, Marta
    Toni, Danilo
    Merkler, Alexander E.
    CIRCULATION RESEARCH, 2022, 130 (08) : 1187 - 1203
  • [45] COVID-19 in children and the importance of COVID-19 vaccination
    Xue, Feng-Xia
    Shen, Kun-Ling
    WORLD JOURNAL OF PEDIATRICS, 2021, 17 (05) : 462 - 466
  • [46] COVID-19 despite full COVID-19 vaccination
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (05)
  • [47] Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19
    Shrestha, Nabin K.
    Burke, Patrick C.
    Nowacki, Amy S.
    Terpeluk, Paul
    Gordon, Steven M.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E662 - E671
  • [48] Uptake of COVID-19 vaccination among people who inject drugs
    Jenny Iversen
    Handan Wand
    Robert Kemp
    Jude Bevan
    Myf Briggs
    Kate Patten
    Sue Heard
    Lisa Maher
    Harm Reduction Journal, 19
  • [49] How frequent are acute reactions to COVID-19 vaccination and who is at risk?
    Dreyer, Nancy
    Reynolds, Matthew W.
    Albert, Lisa
    Brinkley, Emma
    Kwon, Tom
    Mack, Christina
    Toovey, Stephen
    VACCINE, 2022, 40 (12) : 1904 - 1912